The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, Ha et al.[45] showed that R9C pentamer is unable to regulate SERCA’s activity, due to the formation of disulfide bridges between the protomers, a situation that is exacerbated under oxidizing conditions[45, 46].”
From Effects of the Arg9Cys and Arg25Cys mutations on phospholamban's conformational equilibrium in membrane bilayers (2018) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban
Gustavsson, M., Verardi, R., Mullen, D. G., Mote, K. R., Traaseth, N. J., Gopinath, T., & Veglia, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303006110 · Cited by 150
Ha, K. N., Masterson, L. R., Hou, Z., Verardi, R., Walsh, N., Veglia, G., & Robia, S. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013987108 · Cited by 91
Self-citation
Research works printed but not linked: 48
- Lipskaia, 2009, Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation, Pflugers Arch, 457, 673, 10.1007/s00424-007-0428-7 · DOI
- Periasamy, 2001, SERCA pump level is a critical determinant of Ca2+ homeostasis and cardiac contractility, J. Mol. Cell. Cardiol, 33, 1053, 10.1006/jmcc.2001.1366 · DOI · Paper page
- Kranias, 2012, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ. Res, 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
- Simmerman, 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol. Rev, 78, 921, 10.1152/physrev.1998.78.4.921 · DOI · Paper page
- Hagemann, 2002, Dual site phospholamban phosphorylation and its physiological relevance in the heart, Trends Cardiovasc. Med, 12, 51, 10.1016/S1050-1738(01)00145-1 · DOI
- Wegener, 1989, Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to β-adrenergic stimulation, J. Biol. Chem, 264, 11468, 10.1016/S0021-9258(18)60487-9 · DOI · Paper page
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- Schmitt, 2009, Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition, Circulation, 119, 436, 10.1161/CIRCULATIONAHA.108.783506 · DOI · Paper page
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest, 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Medeiros, 2011, Mutations in the human phospholamban gene in patients with heart failure, Am. Heart J, 162, 1088, 10.1016/j.ahj.2011.07.028 · DOI
- Landstrom, 2011, PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing, Am. Heart J, 161, 165, 10.1016/j.ahj.2010.08.001 · DOI
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U.S.A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- DeWitt, 2006, Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy, J. Am. Coll. Cardiol, 48, 1396, 10.1016/j.jacc.2006.07.016 · DOI
- Posch, 2009, Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes, Heart Rhythm, 6, 480, 10.1016/j.hrthm.2009.01.016 · DOI
- van Rijsingen, 2014, Outcome in phospholamban R14del carriers: results of a large multicentre cohort study, Circ. Cardiovasc. Genet, 7, 455, 10.1161/CIRCGENETICS.113.000374 · DOI · Paper page
- Jefferies, 2010, Dilated cardiomyopathy, Lancet, 375, 752, 10.1016/S0140-6736(09)62023-7 · DOI · Paper page
- Dellefave, 2010, The genetics of dilated cardiomyopathy, Curr. Opin. Cardiol, 25, 198, 10.1097/HCO.0b013e328337ba52 · DOI · Paper page
- Parvari, 2012, The mutations associated with dilated cardiomyopathy, Biochem. Res. Int, 2012, 639250, 10.1155/2012/639250 · DOI
- Ceholski, 2012, Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A, J. Biol. Chem, 287, 26596, 10.1074/jbc.M112.382713 · DOI · Paper page
- Ceholski, 2012, Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy, J. Biol. Chem, 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
- Paterlini, 2005, The α-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation, Biophys. J, 88, 3243, 10.1529/biophysj.104.054460 · DOI
- Yu, 2013, Probing the interaction of Arg9Cys mutated phospholamban with phospholipid bilayers by solid-state NMR spectroscopy, Biochim. Biophys. Acta, 1828, 2444, 10.1016/j.bbamem.2013.07.003 · DOI
- Yu, 2014, Secondary structure, backbone dynamics, and structural topology of phospholamban and its phosphorylated and Arg9Cys-mutated forms in phospholipid bilayers utilizing 13C and 15N solid-state NMR spectroscopy, J. Phys. Chem. B, 118, 2124, 10.1021/jp500316s · DOI · Paper page
- Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J. Biol. Chem, 283, 28996, 10.1074/jbc.M804782200 · DOI
- Wegener, 1984, Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits, J. Biol. Chem, 259, 1834, 10.1016/S0021-9258(17)43484-3 · DOI · Paper page
- Hasenfuss, 1998, Animal models of human cardiovascular disease, heart failure and hypertrophy, Cardiovasc. Res, 39, 60, 10.1016/S0008-6363(98)00110-2 · DOI · Paper page
- Pattison, 2008, Phospholamban overexpression in transgenic rabbits, Transgenic Res, 17, 157, 10.1007/s11248-007-9139-2 · DOI
- Bers, 2002, Cardiac excitation-contraction coupling, Nature, 415, 198, 10.1038/415198a · DOI · Paper page
- Hou, 2010, Relative affinity of calcium pump isoforms for phospholamban quantified by fluorescence resonance energy transfer, J. Mol. Biol, 402, 210, 10.1016/j.jmb.2010.07.023 · DOI
- Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem, 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
- Robia, 2007, Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circ. Res, 101, 1123, 10.1161/CIRCRESAHA.107.159947 · DOI
- Kelly, 2008, Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells, J. Biol. Chem, 283, 12202, 10.1074/jbc.M707590200 · DOI
- Autry, 1998, High-level coexpression of the canine cardiac calcium pump and phospholamban in Sf21 insect cells, Ann. N. Y. Acad. Sci, 853, 92, 10.1111/j.1749-6632.1998.tb08259.x · doi:10.1111/j.1749-6632.1998.tb08259.x
- Domeier, 2009, Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure, J. Physiol, 587, 5197, 10.1113/jphysiol.2009.177576 · DOI
- Pallikkuth, 2013, Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase, Biophys. J, 105, 1812, 10.1016/j.bpj.2013.08.045 · DOI · Paper page
- Abrol, 2014, Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex, J. Biol. Chem, 289, 25855, 10.1074/jbc.M114.562579 · DOI
- Zal, 2004, Photobleaching-corrected FRET efficiency imaging of live cells, Biophys. J, 86, 3923, 10.1529/biophysj.103.022087 · DOI · Paper page
- Förster, 1948, Intermolecular energy migration and fluorescence, Ann. Phys, 2, 55, 10.1002/andp.19484370105 · DOI · Paper page
- Li, 1999, A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban, Biophys. J, 76, 2587, 10.1016/S0006-3495(99)77411-4 · DOI
- Robia, 2005, Phospholamban pentamer quaternary conformation determined by in-gel fluorescence anisotropy, Biochemistry, 44, 4302, 10.1021/bi0478446 · DOI
- Runnels, 1995, Theory and application of fluorescence homotransfer to melittin oligomerization, Biophys. J, 69, 1569, 10.1016/S0006-3495(95)80030-5 · DOI · Paper page
- Fujii, 1989, Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation, J. Biol. Chem, 264, 12950, 10.1016/S0021-9258(18)51579-9 · DOI · Paper page
- King, 2014, The FRET signatures of noninteracting proteins in membranes: simulations and experiments, Biophys. J, 106, 1309, 10.1016/j.bpj.2014.01.039 · DOI
- Schröder, 2008, Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations, Curr. Opin. Pharmacol, 8, 153, 10.1016/j.coph.2007.12.012 · DOI
- Gramolini, 2008, Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses, Mol. Cell. Proteomics, 7, 519, 10.1074/mcp.M700245-MCP200 · DOI
- Smeazzetto, 2013, Structure-function relation of phospholamban: modulation of channel activity as a potential regulator of SERCA activity, PLoS One, 8, e52744, 10.1371/journal.pone.0052744 · DOI
- Dong, 2014, Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation, Biochem. Biophys. Res. Commun, 449, 196, 10.1016/j.bbrc.2014.04.166 · DOI · Paper page
- Choudhary, 2002, Heart failure, oxidative stress, and ion channel modulation, Congest. Heart Fail, 8, 148, 10.1111/j.1527-5299.2002.00716.x · DOI
Cited by
Nelson, S. E. D., Ha, K. N., Gopinath, T., Exline, M. H., Mascioni, A., Thomas, D. D., & Veglia, G. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.030 · Cited by 16
Metadata
- Authors
- Abrol, N., de Tombe, P. P., & Robia, S. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 290
- Issue
- 11
- Pages
- 7130-7140
- ISSN
- 0021-9258
- Cited by
- 28
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2028 d)
- Funders
- National Institutes of Health (HL-092321, HL-62426, HL-75494)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban. https://app.cochat.ai/papers/10.1074/jbc.m114.630319
- The paper
- Abrol, N., de Tombe, P. P., & Robia, S. L. (2015). Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m114.630319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.